Results 151 to 160 of about 17,361 (234)

Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature [PDF]

open access: bronze, 2007
Rika Yuliwulandari   +11 more
openalex   +1 more source

Investigating the mechanisms by which low NAT1 expression in tumor cells contributes to chemo-resistance in colorectal cancer

open access: yesClinical Epigenetics
Background In the therapeutic landscape of colorectal cancer (CRC), chemo-resistance poses a significant and prevalent obstacle that complicates treatment efficacy and patient outcomes.
Zheng Yuan   +10 more
doaj   +1 more source

Leukemia Inhibitory Factor Decreases the Arylamine N-Acetyltransferase Activity in Human Cumulus Granulosa Cells [PDF]

open access: bronze, 2001
Chi-Chen Chang   +4 more
openalex   +1 more source

Characterization of an oxidoreductase from the arylamineN‐acetyltransferase operon inMycobacterium smegmatis [PDF]

open access: bronze, 2011
Dimitrios Evangelopoulos   +5 more
openalex   +1 more source

Arylamine N-acetyltransferase 1 expression predicts glucose dependence and mitochondrial bioenergetics in cancer cells.

open access: yesBiochimica et biophysica acta. Molecular cell research
C. Choudhury, N. Butcher, R. Minchin
semanticscholar   +1 more source

Mapping the genes for arylamine N-acetyltransferases

open access: yes, 2000
Arylamine N-acetyltransferases are xenobiotic metabolising enzymes, involved in metabolic pathways leading to either detoxification or bio-activation of drugs and carcinogens. In humans, polymorphisms of the two functional NAT genes (NAT1 and NAT2} have been implicated to cancer susceptibility.
openaire   +2 more sources

Home - About - Disclaimer - Privacy